Showing results (411-420 of 425) with videos related to
Sort By:
Pageof 43
BMJ Open|August 23, 2015
Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic servicesC Czoski Murray, M Twiddy, D Meads, et al.Scientific Reports|April 5, 2018
Endothelial indoleamine 2,3-dioxygenase-1 regulates the placental vascular tone and is deficient in intrauterine growth restriction and pre-eclampsiaPablo Zardoya-Laguardia, Astrid Blaschitz, Birgit Hirschmugl, et al.Nature Communications|November 17, 2021
Hydrogen peroxide signaling via its transformation to a stereospecific alkyl hydroperoxide that escapes reductive inactivationRaphael F Queiroz, Christopher P Stanley, Kathryn Wolhuter, et al.Bioorganic & Medicinal Chemistry|June 16, 2001
Novel mimics of sialyl Lewis X: design, synthesis and biological activity of a series of 2- and 3-malonate substituted galactoconjugatesA Marinier, A Martel, C Bachand, et al.JACC. Basic to Translational Science|December 12, 2025
Epigenetic Reprogramming via TET2 Prevents Medial Calcification and Restores Vascular Smooth Muscle Cell IdentityBob S L Lee, Joshua K Dunn, Cassandra Liang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer GroupJ L Finlay, S Goldman, M C Wong, et al.Journal of Neurosurgery|April 3, 1998
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer GroupP L Robertson, P M Zeltzer, J M Boyett, et al.British Journal of Cancer|September 23, 2010
Melanoma sentinel node biopsy and prediction models for relapse and overall survivalA Mitra, C Conway, C Walker, et al.Pediatric Neurosurgery|January 1, 1996
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group StudyM Deutsch, P R Thomas, J Krischer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III studyP M Zeltzer, J M Boyett, J L Finlay, et al.Pageof 43